![_ngi0464[002]](https://www.inventech.nl/cache/0e3c356f50729db299a91cd3ebb4b94c/_ngi0464[002].jpg)
Advanced particle characterization
EOSClassizer™ ONE, equipped with advanced SPES/SPES² technology, offers exceptional particle characterization for pharmaceutical applications, including drug delivery system (DDS) analysis. It is also particularly suited for effectively analyzing mixtures of particles and biological components, such as blood cells in biological liquids (e.g., serum, plasma, urine, and cell lysate).
This instrument provides detailed, high-resolution insights into submicron and micron-sized particles, which are essential for the development of effective drug carriers like poly(lactic-co-glycolic acid) (PLGA) particles. This particle analysis helps optimize drug delivery system formulations and improve pharmaceutical product development.
Classizer™ ONE enables real-time monitoring of particle size distribution, morphology, and drug release dynamics. This offers researchers the ability to refine drug carriers for better bioavailability, enhanced therapeutic effectiveness, and improved patient compliance. The system is indispensable for pharmaceutical researchers seeking advanced particle characterization to develop innovative pharmaceutical products and enhance drug safety and efficacy.
Key benefits
Nanomaterials often consist of mixtures of fully or partially biobased materials. Think of biomedical materials and polymer mixtures. In R&D and quality control of these mixtures, traditional methods such as LD and DLS provide averaged data over the entire sample. In doing so, all particles are considered the same, just with different sizes. This can be a limitation in various R&D and QC tasks. SPES particle characterization method solves this problem.
What would you like to measure?
Contact us for more information, we are happy to help.